Proposed Update to the CDC Framework for Program Evaluation in Public Health; Extension of Comment Period, 5347-5348 [2023-01695]
Download as PDF
<![CDATA[
5347
Federal Register / Vol. 88, No. 18 / Friday, January 27, 2023 / Notices
Questions may undergo cognitive
testing because they have not been used
in previous surveys; for example,
questions related to the emergence of a
new public health concern (such as ecigarettes). In addition, testing may be
conducted on previously used questions
to assess their use in a different
information collection mode; for
example, testing might be conducted to
convert questions developed for a paper
survey to an interview format or an
electronic survey format; or testing
might be conducted to identify issues
specific to a subpopulation or language
translation. Respondents are asked to
review questions and/or surveys to
discuss their impressions of the items
under consideration, the questions, the
response set, individual words within
the question, or the focus of the
questionnaire itself. Incentives may be
offered to respondents who participate
in the in-person phase of cognitive
testing since these activities involve
additional burden and inconvenience.
Pilot testing is used to determine
whether methods or modes of data
collection (such as phone or mail
surveys, in-person interviews or online
data collection) are appropriate and
efficient ways of collecting data. Pilot
testing may include testing of changes
in sampling or contacting potential
respondents.
The majority of participants in
cognitive and pilot testing activities are
expected to be adults ≤ 18 years of age.
Information may be collected during the
recruitment process to assist in the
selection of respondents. Respondents
may be recruited to take part in testing
through online or newspaper
advertisements. If the participants are
not recruited to be present at a physical
location, they may be called and
recruited by telephone.
Cognitive and pilot testing are
efficient means of identifying problems
with questions and procedures prior to
implementation of data collection.
Thus, they are cost effective approaches
to providing evidence on survey
questionnaire performance. A
consequence of cognitive and pilot
testing is to maintain high levels of
participation in the information
collection process itself.
Initial response and burden estimates
are based on anticipated information
collection needs for the Generic
Information Collection Request for
Cognitive Testing and Pilot Testing for
the National Center for Chronic Disease
Prevention and Health Promotion, with
an additional allocation for a variety of
NCCDPHP programs and collaborators.
Each information collection activity
conducted through this Generic will be
submitted to OMB for approval in a
project-specific information collection
request that describes its purpose and
methods.
Participation in cognitive and pilot
testing is voluntary, but respondents
will be encouraged to participate by
explanations of the need for their input
in the introduction of each survey. CDC
requests OMB approval for an estimated
35,850 annual burden hours. There are
no costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
General U.S. Population or Selected Subpopulation Screening for Pilot Testing.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–01668 Filed 1–26–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
khammond on DSKJM1Z7X2PROD with NOTICES
[Docket No. CDC–2022–0137]
Proposed Update to the CDC
Framework for Program Evaluation in
Public Health; Extension of Comment
Period
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
16:53 Jan 26, 2023
Number of
respondents
Form name
Jkt 259001
Number of
responses per
respondent
Average
burden
per response
(in hours)
Screening for Cognitive testing ......................
2,500
1
15/60
Screening for Pilot Testing .............................
Cognitive Testing in Person ...........................
Cognitive Testing by Phone ...........................
Cognitive Testing by ABS/Mail/Web ..............
Pilot Testing in Person ...................................
Pilot Testing by Phone ...................................
Pilot Testing by ABS/Mail/Web ......................
40,000
1,500
1,500
600
1,000
3000
40,000
1
1
1
1
1
1
1
15/60
60/60
45/60
60/60
30/60
30/60
30/60
Request for information and
extension of comment period.
ACTION:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the
extension of the comment period for the
update to the CDC Framework for
Program Evaluation in Public Health
(CDC Evaluation Framework) and
associated resources (e.g., checklists,
self-study guide).
DATES: Written comments must be
received on or before February 17, 2023.
Comments received after February 17,
2023, will not be considered.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0137 by either of the methods listed
below. Do not submit comments by
email. CDC does not accept comments
by email.
SUMMARY:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Centers for Disease Control
and Prevention, Program Performance
and Evaluation Office, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta, GA
30329–4027.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Daniel Kidder, CDC Chief Evaluation
Officer, Centers for Disease Control and
Prevention, Program Performance and
Evaluation Office, 1600 Clifton Road
NE, Mailstop H21–10, Atlanta, GA
E:\FR\FM\27JAN1.SGM
27JAN1
5348
Federal Register / Vol. 88, No. 18 / Friday, January 27, 2023 / Notices
30329–4027; Telephone: 404–639–6270;
Email: CDCeval@cdc.gov.
On
November 29, 2022, CDC published a
notice requesting public comment and
suggestions to update the CDC
Evaluation Framework (87 FR 73311).
The comment period was scheduled to
close on January 30, 2023. CDC has
received requests from the public to
extend the comment period. With this
notice, CDC is extending the comment
period through February 17, 2023, to
accommodate those requests. Comments
received after February 17, 2023, will
not be considered.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Background
The flexibility and simplicity of the
CDC Evaluation Framework have led to
its wide adoption and use beyond CDC
and public health. The CDC Evaluation
Framework has guided CDC and other
evaluators over two decades, as
evidenced by more than 300 citations in
peer-reviewed articles and use in
projects reaching more than 50
countries on six continents. However,
evaluation has evolved since
publication of the framework in 1999; 1
therefore, CDC seeks to update the
framework to align with changes in
evaluation, public health, and federal
policies and practices.
The comments from this request for
information, along with input gathered
through other mechanisms (e.g.,
townhall with CDC, interviews with key
federal evaluators, surveys with federal
evaluation staff and leaders), will help
identify how the framework may have
been adapted and used in different
settings, what aspects of the framework
have been useful, any challenges in
using the framework across different
contexts, and gaps that may need to be
addressed. CDC is gathering input from
a variety of audiences, such as federal
evaluators, CDC staff, and CDC funded
partners. Feedback from these sources
will be considered in determining
priority areas to update and revise in the
CDC Evaluation Framework to continue
its valuable use and service to the
evaluation field and public health. The
relevant feedback along with tools,
evidence, and resources in the field and
literature will also be considered in
determining whether to update, revise,
or create new content for the CDC
Evaluation Framework and supporting
resources (e.g., checklists, tools).
1 Centers for Disease Control and Prevention.
Framework for program evaluation in public health.
MMWR 1999;48 (No. RR–11).
VerDate Sep<11>2014
16:53 Jan 26, 2023
Jkt 259001
Request for Information
Interested persons or organizations
are invited to submit written views,
information, and recommendations.
CDC invites comments specifically on
the following questions, along with
suggestions for improving the CDC
Evaluation Framework:
1. How has the current CDC
Evaluation Framework assisted or not
assisted the public health community in
planning and conducting high-quality
program evaluations? What specifically
helped or did not help?
2. Which contexts has the current
CDC Evaluation Framework worked
well for and for which contexts has it
not worked well? What specifically did
or did not work and why?
3. How does the current CDC
Evaluation Framework promote or
inhibit the conduct of evaluations that
are culturally responsive and address
health equity? What opportunities for
improvement exist?
Please be clear and specific in the
comments so that CDC can consider the
feedback provided in determining
whether to change or keep specific
aspects of the CDC Evaluation
Framework. The CDC Evaluation
Framework and associated resources
can be found here in the Supporting
Materials tab of the docket and at
https://www.cdc.gov/evaluation/
framework/index.htm.
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign.
Tiffany Brown,
Acting Executive Secretary, Centers for
Disease Control and Prevention.
[FR Doc. 2023–01695 Filed 1–26–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Extension of Temporary
Suspension of Dogs Entering the
United States From Countries With a
High Risk of Rabies
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces an extension
of the current temporary suspension of
the importation into the United States of
dogs from high-risk rabies-enzootic
countries (high-risk countries). This
suspension includes dogs that have
been in any high-risk countries during
the previous six months.
DATES: The extension of the temporary
suspension of the importation of dogs
into the United States from high-risk
countries will be implemented on
February 1, 2023, when the current
suspension expires, and will remain in
effect through July 31, 2023.
FOR FURTHER INFORMATION CONTACT:
Ashley C. Altenburger, J.D., Division of
Global Migration and Quarantine,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H16–4, Atlanta, GA 30329. Telephone:
1–800–232–4636. For information
regarding CDC regulations for the
importation of dogs: Dr. Emily Pieracci,
D.V.M., Division of Global Migration
and Quarantine, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS H16–4, Atlanta, GA
30329. Telephone: 1–800–232–4636.
SUPPLEMENTARY INFORMATION: CDC is
extending, but not modifying, the terms
of the current temporary suspension. A
suspension remains necessary to protect
the public’s health against the
reintroduction of the dog-maintained
rabies virus variant (DMRVV) into the
United States. There is a continued
threat posed by unvaccinated or
inadequately vaccinated dogs from highrisk countries due to various factors.
These include insufficient veterinary
controls in high-risk countries to
prevent the export of inadequately
vaccinated dogs, and veterinary supply
chain and workforce capacity shortages
that have persisted since the global
COVID–19 pandemic. These factors
result in challenges to efforts to ensure
dogs imported into the United States do
not pose a public health threat. CDC
SUMMARY:
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 88, Number 18 (Friday, January 27, 2023)]
[Notices]
[Pages 5347-5348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01695]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2022-0137]
Proposed Update to the CDC Framework for Program Evaluation in
Public Health; Extension of Comment Period
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for information and extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), announces the
extension of the comment period for the update to the CDC Framework for
Program Evaluation in Public Health (CDC Evaluation Framework) and
associated resources (e.g., checklists, self-study guide).
DATES: Written comments must be received on or before February 17,
2023. Comments received after February 17, 2023, will not be
considered.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0137 by either of the methods listed below. Do not submit comments by
email. CDC does not accept comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, Program
Performance and Evaluation Office, 1600 Clifton Road NE, Mailstop H21-
10, Atlanta, GA 30329-4027.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to https://regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Daniel Kidder, CDC Chief Evaluation
Officer, Centers for Disease Control and Prevention, Program
Performance and Evaluation Office, 1600 Clifton Road NE, Mailstop H21-
10, Atlanta, GA
[[Page 5348]]
30329-4027; Telephone: 404-639-6270; Email: [email protected].
SUPPLEMENTARY INFORMATION: On November 29, 2022, CDC published a notice
requesting public comment and suggestions to update the CDC Evaluation
Framework (87 FR 73311). The comment period was scheduled to close on
January 30, 2023. CDC has received requests from the public to extend
the comment period. With this notice, CDC is extending the comment
period through February 17, 2023, to accommodate those requests.
Comments received after February 17, 2023, will not be considered.
Background
The flexibility and simplicity of the CDC Evaluation Framework have
led to its wide adoption and use beyond CDC and public health. The CDC
Evaluation Framework has guided CDC and other evaluators over two
decades, as evidenced by more than 300 citations in peer-reviewed
articles and use in projects reaching more than 50 countries on six
continents. However, evaluation has evolved since publication of the
framework in 1999; \1\ therefore, CDC seeks to update the framework to
align with changes in evaluation, public health, and federal policies
and practices.
---------------------------------------------------------------------------
\1\ Centers for Disease Control and Prevention. Framework for
program evaluation in public health. MMWR 1999;48 (No. RR-11).
---------------------------------------------------------------------------
The comments from this request for information, along with input
gathered through other mechanisms (e.g., townhall with CDC, interviews
with key federal evaluators, surveys with federal evaluation staff and
leaders), will help identify how the framework may have been adapted
and used in different settings, what aspects of the framework have been
useful, any challenges in using the framework across different
contexts, and gaps that may need to be addressed. CDC is gathering
input from a variety of audiences, such as federal evaluators, CDC
staff, and CDC funded partners. Feedback from these sources will be
considered in determining priority areas to update and revise in the
CDC Evaluation Framework to continue its valuable use and service to
the evaluation field and public health. The relevant feedback along
with tools, evidence, and resources in the field and literature will
also be considered in determining whether to update, revise, or create
new content for the CDC Evaluation Framework and supporting resources
(e.g., checklists, tools).
Request for Information
Interested persons or organizations are invited to submit written
views, information, and recommendations. CDC invites comments
specifically on the following questions, along with suggestions for
improving the CDC Evaluation Framework:
1. How has the current CDC Evaluation Framework assisted or not
assisted the public health community in planning and conducting high-
quality program evaluations? What specifically helped or did not help?
2. Which contexts has the current CDC Evaluation Framework worked
well for and for which contexts has it not worked well? What
specifically did or did not work and why?
3. How does the current CDC Evaluation Framework promote or inhibit
the conduct of evaluations that are culturally responsive and address
health equity? What opportunities for improvement exist?
Please be clear and specific in the comments so that CDC can
consider the feedback provided in determining whether to change or keep
specific aspects of the CDC Evaluation Framework. The CDC Evaluation
Framework and associated resources can be found here in the Supporting
Materials tab of the docket and at https://www.cdc.gov/evaluation/framework/index.htm.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near duplicate examples of a mass-mail campaign.
Tiffany Brown,
Acting Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2023-01695 Filed 1-26-23; 8:45 am]
BILLING CODE 4163-18-P
